Please try another search
Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.
Name | Age | Since | Title |
---|---|---|---|
Susann Brady-Kalnay | - | 2022 | Member of Scientific Advisory Board |
Paul Edward-Alexander Hopper | 66 | 2021 | Founder & Executive Chairman |
David Ulmert | - | - | Member of Scientific Advisory Board |
Sara Hurvitz | - | - | Member of Scientific Advisory Board |
Johannes Notni | - | - | Member of Scientific Advisory Board |
Leila Alland | 60 | 2022 | Non-Executive Director |
Eric Aboagye | - | - | Member of Scientific Advisory Board |
Hoi Ting Hong | - | - | Member of Scientific Advisory Board |
Ian Turner | - | 2021 | Non-Executive Director |
Hester Larkin | - | 2022 | Non-Executive Director |
Riccardo Canevari | - | 2021 | MD, CEO & Director |
Ken Herrmann | - | 2023 | Member of Scientific Advisory Board |
David Mozley | - | - | Chief Medical Officer & Scientific Advisory Board Chair |
Phillip Hains | - | 2024 | CFO, Company Secretary & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review